A citation-based method for searching scientific literature


List of co-cited articles
316 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
64

Assessment of a HER2 scoring system for gastric cancer: results from a validation study.
M Hofmann, O Stoss, D Shi, R Büttner, M van de Vijver, W Kim, A Ochiai, J Rüschoff, T Henkel. Histopathology 2008
812
57


HER2 testing in gastric cancer: a practical approach.
Josef Rüschoff, Wedad Hanna, Michael Bilous, Manfred Hofmann, Robert Y Osamura, Frédérique Penault-Llorca, Marc van de Vijver, Giuseppe Viale. Mod Pathol 2012
359
35

HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.
Josef Rüschoff, Manfred Dietel, Gustavo Baretton, Susanne Arbogast, Axel Walch, Geneviéve Monges, Marie-Pierre Chenard, Frédérique Penault-Llorca, Iris Nagelmeier, Werner Schlake,[...]. Virchows Arch 2010
341
28

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
M Tanner, M Hollmén, T T Junttila, A I Kapanen, S Tommola, Y Soini, H Helin, J Salo, H Joensuu, E Sihvo,[...]. Ann Oncol 2005
517
26

Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis.
Y Y Janjigian, D Werner, C Pauligk, K Steinmetz, D P Kelsen, E Jäger, H M Altmannsberger, E Robinson, L J Tafe, L H Tang,[...]. Ann Oncol 2012
224
24

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
Chao He, Xue-Yi Bian, Xing-Zhi Ni, Dan-Ping Shen, Yan-Ying Shen, Hua Liu, Zhi-Yong Shen, Qiang Liu. World J Gastroenterol 2013
67
24


HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
Pamela L Kunz, Amirkaveh Mojtahed, George A Fisher, James M Ford, Daniel T Chang, Raymond R Balise, Charles D Bangs, Athena M Cherry, Reetesh K Pai. Appl Immunohistochem Mol Morphol 2012
91
22

HER2 expression and its clinicopathological features in resectable gastric cancer.
Yoshiki Kataoka, Hiroshi Okabe, Akihiko Yoshizawa, Sachiko Minamiguchi, Kenichi Yoshimura, Hironori Haga, Yoshiharu Sakai. Gastric Cancer 2013
67
22

Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays.
Kab Choong Kim, Young Wha Koh, Heung-Moon Chang, Tae Hwan Kim, Jeong Hwan Yook, Byung Sik Kim, Se Jin Jang, Young Soo Park. Ann Surg Oncol 2011
119
22

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer.
Eric Van Cutsem, Yung-Jue Bang, Feng Feng-Yi, Jian M Xu, Keun-Wook Lee, Shun-Chang Jiao, Jorge León Chong, Roberto I López-Sanchez, Timothy Price, Oleg Gladkov,[...]. Gastric Cancer 2015
254
22

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma.
C Bozzetti, F V Negri, C A Lagrasta, P Crafa, C Bassano, I Tamagnini, G Gardini, R Nizzoli, F Leonardi, D Gasparro,[...]. Br J Cancer 2011
110
21

HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Dong Il Park, Jung Won Yun, Jung Ho Park, Suk Joong Oh, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Chang Hak Yoo,[...]. Dig Dis Sci 2006
219
21

HER2 expression in gastric cancer: Rare, heterogeneous and of no prognostic value - conclusions from 924 cases of two independent series.
Heike Grabsch, Shivan Sivakumar, Sally Gray, Helmut E Gabbert, Wolfram Müller. Cell Oncol 2010
209
19

HER2-positive gastric cancer.
Narikazu Boku. Gastric Cancer 2014
194
19

Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
Tomonori Yano, Toshihiko Doi, Atsushi Ohtsu, Narikazu Boku, Kaoru Hashizume, Mamoru Nakanishi, Atsushi Ochiai. Oncol Rep 2006
170
17

HER-2 amplification is highly homogenous in gastric cancer.
Andreas H Marx, Lars Tharun, Johanna Muth, Ana-Maria Dancau, Ronald Simon, Emre Yekebas, Jussuf T Kaifi, Martina Mirlacher, Tim H Brümmendorf, Carsten Bokemeyer,[...]. Hum Pathol 2009
166
17

Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.
Masaki Aizawa, Akiko K Nagatsuma, Koji Kitada, Takeshi Kuwata, Satoshi Fujii, Taira Kinoshita, Atsushi Ochiai. Gastric Cancer 2014
45
22

A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
Junhun Cho, Jiyun Jeong, Jiyoun Sung, Chang Ohk Sung, Kyoung-Mee Kim, Cheol Keun Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Sung Kim. Ann Surg Oncol 2013
31
32

HER2 testing in gastric cancer.
Luca Albarello, Lorenza Pecciarini, Claudio Doglioni. Adv Anat Pathol 2011
114
17


HER2 expression in gastric cancer in Indian population--an immunohistochemistry and fluorescence in situ hybridization study.
Anuradha Sekaran, Raja Sekhar Kandagaddala, Santosh Darisetty, Sandeep Lakhtakia, Santa Ayyagari, Guduru Venkat Rao, Pradeep Rebala, Duvvuru Bhaskara Reddy, Duvvuru Nageshwar Reddy. Indian J Gastroenterol 2012
17
52


Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections.
Stephen Lee, Willem Bastiaan de Boer, Soraya Fermoyle, Michael Platten, Marian Priyanthi Kumarasinghe. Histopathology 2011
91
15

Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis.
Shuyi Wang, Gang Zheng, Liangdong Chen, Bin Xiong. Asian Pac J Cancer Prev 2011
36
25


Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients.
J D Barros-Silva, D Leitão, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, M J Bento, L Santos, P Ferreira, S Rêgo,[...]. Br J Cancer 2009
125
14

Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.
Mitsugu Kochi, Masashi Fujii, Shinobu Masuda, Noriaki Kanamori, Yoshiaki Mihara, Tomoya Funada, Hidenori Tamegai, Megumu Watanabe, Hiroshi Suda, Tadatoshi Takayama. Diagn Pathol 2013
31
25

A study of HER2 gene amplification and protein expression in gastric cancer.
Benedict Yan, Ee Xuan Yau, Siti Shyba Bte Omar, Chee Wee Ong, Brendan Pang, Khay Guan Yeoh, Manuel Salto-Tellez. J Clin Pathol 2010
86
14

Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.
Shi-Yan Yan, Ying Hu, Jian-Gao Fan, Guo-Quan Tao, Yong-Ming Lu, Xu Cai, Bao-Hua Yu, Yi-Qun Du. World J Gastroenterol 2011
67
14

Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
Jiyuan Yang, Hesheng Luo, Yan Li, Junchuan Li, Zhiqiang Cai, Xiaoyan Su, Danqing Dai, Wei Du, Tingxuan Chen, Ming Chen. Cell Biochem Biophys 2012
83
14

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.
T Akiyama, C Sudo, H Ogawara, K Toyoshima, T Yamamoto. Science 1986
736
14

HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas.
Indu Rajagopal, S R Niveditha, R Sahadev, Preethan Kamagere Nagappa, Sowmya Goddanakoppal Rajendra. J Clin Diagn Res 2015
17
47

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
12

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
Y Yonemura, I Ninomiya, A Yamaguchi, S Fushida, H Kimura, S Ohoyama, I Miyazaki, Y Endou, M Tanaka, T Sasaki. Cancer Res 1991
292
12

Targeted HER2 treatment in advanced gastric cancer.
Jan Trøst Jørgensen. Oncology 2010
110
12

Clinical significance of intratumoral HER2 heterogeneity in gastric cancer.
Hee Eun Lee, Kyoung Un Park, Seol Bong Yoo, Soo Kyung Nam, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee. Eur J Cancer 2013
111
12

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia.
Stephen B Fox, Marian Priyanthi Kumarasinghe, Jane E Armes, Michael Bilous, Margaret C Cummings, Gelareh Farshid, Nicole Fitzpatrick, Glenn D Francis, Philip I McCloud, Wendy Raymond,[...]. Am J Surg Pathol 2012
34
20

Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas.
Eun Yoon Cho, Kyeongmee Park, Ingu Do, Junhun Cho, Jiyun Kim, Jeeyun Lee, Seonwoo Kim, Kyoung-Mee Kim, Tae Sung Sohn, Won Ki Kang,[...]. Mod Pathol 2013
63
12

HER2 status in gastric and gastroesophageal junction cancer assessed by local and central laboratories: Chinese results of the HER-EAGLE study.
Dan Huang, Ning Lu, Qinhe Fan, Weiqi Sheng, Hong Bu, Xiaolong Jin, Guimei Li, Yanhui Liu, Xianghong Li, Wenyong Sun,[...]. PLoS One 2013
31
22

Are biopsy specimens predictive of HER2 status in gastric cancer patients?
M Pirrelli, M L Caruso, M Di Maggio, R Armentano, A M Valentini. Dig Dis Sci 2013
37
18

Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Virchows Arch 2014
35
20

HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily.
A Ieni, V Barresi, G Giuffrè, R A Caruso, S Lanzafame, L Villari, E Salomone, E Roz, D Cabibi, V Franco,[...]. Oncol Lett 2013
23
30

Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis.
Hai-Zhen Dang, Yang Yu, Shun-Chang Jiao. World J Gastroenterol 2012
39
17

Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.
Tao Wang, Eugene T Hsieh, Pauline Henry, Wedad Hanna, Catherine J Streutker, Andrea Grin. Hum Pathol 2014
41
17


Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
Masanori Terashima, Koji Kitada, Atsushi Ochiai, Wataru Ichikawa, Issei Kurahashi, Shinichi Sakuramoto, Hitoshi Katai, Takeshi Sano, Hiroshi Imamura, Mitsuru Sasako. Clin Cancer Res 2012
173
10

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors.
V S Warneke, H-M Behrens, C Böger, T Becker, F Lordick, M P A Ebert, C Röcken. Ann Oncol 2013
87
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.